Turnstone Biologics — Company Overview, News & Financial Data

Turnstone Biologics (NASDAQ:TSBX) is a biotechnology firm dedicated to revolutionizing cancer treatment through the development of innovative oncolytic viral immunotherapies and cancer vaccines. Leveraging cutting-edge science, Turnstone's diverse projects aim to harness the power of the body's immune system to target and destroy cancer cells, offering hope for more effective treatments with fewer side effects. The company is focused on advancing its pipeline of novel therapies through clinical trials, with the objective of achieving breakthroughs in cancer care and improving patient outcomes.